Immunocore Holdings Statistics
Total Valuation
IMCR has a market cap or net worth of $1.65 billion. The enterprise value is $1.22 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IMCR has 50.39 million shares outstanding. The number of shares has increased by 0.95% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.39M |
| Shares Change (YoY) | +0.95% |
| Shares Change (QoQ) | -3.19% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 80.45% |
| Float | 37.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.64 |
| Forward PS | 4.16 |
| PB Ratio | 4.28 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | 58.44 |
| P/OCF Ratio | 49.52 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 42.76 |
Financial Position
The company has a current ratio of 5.89, with a Debt / Equity ratio of 1.12.
| Current Ratio | 5.89 |
| Quick Ratio | 5.60 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | 15.34 |
| Interest Coverage | -1.63 |
Financial Efficiency
Return on equity (ROE) is -5.43% and return on invested capital (ROIC) is -2.14%.
| Return on Equity (ROE) | -5.43% |
| Return on Assets (ROA) | -1.69% |
| Return on Invested Capital (ROIC) | -2.14% |
| Return on Capital Employed (ROCE) | -3.11% |
| Revenue Per Employee | $722,404 |
| Profits Per Employee | -$41,201 |
| Employee Count | 493 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 6.14 |
Taxes
| Income Tax | -2.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.30% in the last 52 weeks. The beta is 0.77, so IMCR's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -12.30% |
| 50-Day Moving Average | 34.02 |
| 200-Day Moving Average | 31.30 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 314,674 |
Short Selling Information
| Short Interest | 8.34M |
| Short Previous Month | 8.44M |
| Short % of Shares Out | 22.80% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 30.80 |
Income Statement
In the last 12 months, IMCR had revenue of $356.15 million and -$20.31 million in losses. Loss per share was -$0.41.
| Revenue | 356.15M |
| Gross Profit | 328.78M |
| Operating Income | -28.39M |
| Pretax Income | -57.12M |
| Net Income | -20.31M |
| EBITDA | -24.56M |
| EBIT | -28.39M |
| Loss Per Share | -$0.41 |
Full Income StatementBalance Sheet
The company has $882.81 million in cash and $436.46 million in debt, giving a net cash position of $446.35 million or $8.86 per share.
| Cash & Cash Equivalents | 882.81M |
| Total Debt | 436.46M |
| Net Cash | 446.35M |
| Net Cash Per Share | $8.86 |
| Equity (Book Value) | 388.48M |
| Book Value Per Share | 7.71 |
| Working Capital | 832.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $33.58 million and capital expenditures -$5.12 million, giving a free cash flow of $28.45 million.
| Operating Cash Flow | 33.58M |
| Capital Expenditures | -5.12M |
| Free Cash Flow | 28.45M |
| FCF Per Share | $0.56 |
Full Cash Flow StatementMargins
Gross margin is 92.32%, with operating and profit margins of -7.97% and -5.70%.
| Gross Margin | 92.32% |
| Operating Margin | -7.97% |
| Pretax Margin | -6.27% |
| Profit Margin | -5.70% |
| EBITDA Margin | -6.90% |
| EBIT Margin | -7.97% |
| FCF Margin | 7.99% |
Dividends & Yields
IMCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.95% |
| Shareholder Yield | -0.95% |
| Earnings Yield | -1.22% |
| FCF Yield | 1.71% |
Dividend DetailsAnalyst Forecast
The average price target for IMCR is $58.13, which is 77.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.13 |
| Price Target Difference | 77.23% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 22.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IMCR has an Altman Z-Score of 1.53 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 5 |
